Učitavanje...
Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
Combination antiretroviral therapy (cART) is effective but not curative, and no successful vaccine is currently available for human immunodeficiency virus-1 (HIV-1). Broadly neutralizing antibodies (bNAbs) provide a new approach to HIV-1 prevention and treatment, and these promising candidates advan...
Spremljeno u:
| Izdano u: | Emerg Microbes Infect |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7040474/ https://ncbi.nlm.nih.gov/pubmed/31985356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/22221751.2020.1713707 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|